Consistent with our previous findings in colon cancer cells (Athamneh et al., 2017), RCE treatment decreased Beclin-1 levels in a concentration-dependent manner in Panc-1 (Figure 6B) and Mia-Paca-2 (Supplementary Figure S3) cells. This evidence concerns the gene BECN1 and malignant colon neoplasm.